Nabriva Therapeutics plc Proceeds from Warrant Exercises
Nabriva Therapeutics plc reported Proceeds from Warrant Exercises of $665.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-04-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2023-04-17
- Nabriva Therapeutics plc proceeds from warrant exercises for the quarter ending 2020-12-31 was $0.00.
- Nabriva Therapeutics plc proceeds from warrant exercises for fiscal 2020 was $665.00K.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $665.00K 10-K · filed 2023-04-17 | |
| 2020-09-30 | $665.00K 10-Q · filed 2020-11-05 |